This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Arrhythmias  • Cardiovascular Intervention  • Revascularization  • Psychiatry  • Depression  • Alert me on articles by topic

Mike Mitka

JAMA. 2005;293:283-284.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New Orleans—People with cardiovascular disease are more likely to be clinically depressed and some seemingly healthy people with depression are at greater risk of developing heart problems. While scientists have yet to show that treating depression reduces cardiovascular mortality rates, evidence continues to mount that treating people with depression does improve their dysphoria and quality of life and may increase longevity (Glassman et al. JAMA. 2002;288:701-709; Musselman et al. Arch Gen Psychiatry. 1998;55:580-592).

Investigators are uncovering the ways depression is related to a variety of cardiovascular complications, opening new avenues for future treatment success. As research presented in November at the Scientific Sessions of the American Heart Association revealed, scientists are documenting the link among depression, infection, and immunity after coronary artery bypass grafting (CABG) and how treating major depression in such patients can prevent a decline in immunity and an increase in infection. They . . . [Full Text of this Article]

DEPRESSION AND IMMUNITY